Skip to main content

Want a detailed portfolio tracker?

Minerva Neurosciences (NERV) P/E (2014 - 2026)

Minerva Neurosciences (NERV) P/E from Jul 1, 2014 to Jul 21, 2026. The TTM Minerva Neurosciences (NERV) P/E is -0.47. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Minerva Neurosciences (NERV)

YearP/EChange
2026-0.47-21.25%
2025-0.60-100.69%
202486.31-901.52%
2023-10.77+640.19%
2022-1.45-73.48%
2021-5.49-101.62%
2020338.18-1199.14%
2019-30.77-26.26%
2018-41.72-3.86%
2017-43.40-52.94%
2016-92.22+108.03%
2015-44.33+281.96%
2014-11.61N/A

Comparison Minerva Neurosciences (NERV) P/E with competitors

Minerva Neurosciences (NERV) P/E is -0.47.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.36%
NBYStablecoin Development Corp0.00-100.91%
ENLVEnlivex Ltd0.07-115.90%
FGENFibroGen Inc0.24-151.02%
CHRSCoherus Biosciences Inc0.85-280.36%
FBIOFortress Biotech Inc0.95-301.72%
ORMPOramed Pharmaceuticals Inc1.50-419.48%
AGENAgenus Inc3.01-739.70%
INVAInnoviva Inc3.15-770.39%
VXRTVaxart Inc3.55-854.50%
CRMDCorMedix Inc3.63-871.23%
CVACCureVac N.V.4.45-1044.93%
GLPGGalapagos NV4.86-1132.76%
SRPTSarepta Therapeutics Inc4.88-1137.69%
ABEOAbeona Therapeutics Inc5.39-1245.12%
ABUSArbutus Biopharma Corp5.60-1289.35%
ZVRAZevra Therapeutics Inc5.89-1351.34%
SPROSpero Therapeutics Inc6.23-1423.86%
CGENCompugen Ltd6.31-1442.04%
RIGLRigel Pharmaceuticals6.87-1560.67%
SLXNSilexion Therapeutics Corp7.30-1650.79%
OMEROmeros Corporation9.26-2067.96%
AUPHAurinia Pharmaceuticals Inc9.58-2137.30%
PLXProtalix BioTherapeutics Inc10.89-2414.90%
ACADAcadia Pharmaceuticals Inc11.73-2592.92%
TBPHTheravance Biopharma Inc12.26-2706.34%
ADMAAdma Biologics Inc12.42-2739.50%
HRMYHarmony Biosciences Holdings Inc13.82-3037.51%
SABSSAB Biotherapeutics Inc14.14-3104.68%
NAGENiagen Bioscience Inc14.82-3249.62%
INCYIncyte Corp15.82-3463.11%
REGNRegeneron Pharmaceuticals Inc15.86-3470.36%
PBYIPuma Biotechnology Inc17.32-3780.49%
CPRXCatalyst Pharmaceuticals Inc17.44-3806.76%
EXELExelixis Inc17.54-3827.74%
TGTXTG Therapeutics Inc18.97-4131.27%
MDXGMimedx Group Inc20.55-4468.48%
XOMAXOMA Royalty Corp22.87-4962.19%
ARGXArgen X SE24.30-5264.73%
CTMXCytomX Therapeutics Inc24.82-5375.92%
XOMAOXOMA Royalty Corp25.34-5487.23%
HALOHalozyme Therapeutics Inc25.62-5546.52%
XOMAPXOMA Royalty Corp25.67-5556.38%
VRTXVertex Pharmaceuticals Inc27.99-6050.49%
RPRXRoyalty Pharma plc - Class A28.69-6197.76%
SLNOSoleno Therapeutics Inc29.02-6267.43%
ASNDAscendis Pharma A/S30.09-6494.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-8158.49%
APLSApellis Pharmaceuticals Inc39.02-8394.26%
BMRNBiomarin Pharmaceutical Inc42.21-9072.45%
KRYSKrystal Biotech Inc45.34-9738.10%
ONCBeiGene Ltd69.54-14881.36%
PHARPharming Group N.V.75.03-16047.27%
TECHBio-Techne Corp101.96-21772.05%
VCELVericel Corp109.92-23464.64%
ALNYAlnylam Pharmaceuticals Inc117.96-25174.40%
GMABGenmab140.29-29919.89%
TLXTelix Pharmaceuticals Ltd162.15-34566.85%
CORTCorcept Therapeutics Inc212.86-45344.52%